AstraZeneca
AZN
#68
Rank
C$354.04 B
Marketcap
C$228.28
Share price
0.95%
Change (1 day)
-3.76%
Change (1 year)

Market capitalization of AstraZeneca (AZN)

Market cap: C$354.04 Billion

As of October 2026 AstraZeneca has a market cap of C$354.04 Billion. This makes AstraZeneca the world's 68th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AstraZeneca from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026C$354.04 B-10.19%
2025C$394.23 B34.93%
2024C$292.17 B5.31%
2023C$277.44 B-2.82%
2022C$285.48 B23.44%
2021C$231.27 B38.47%
2020C$167.01 B-2.29%
2019C$170.92 B32.89%
2018C$128.62 B17.42%
2017C$109.54 B18.19%
2016C$92.67 B-22.73%
2015C$119.93 B15.39%
2014C$103.93 B31.76%
2013C$78.88 B35.32%
2012C$58.29 B-5.33%
2011C$61.57 B-5.36%
2010C$65.05 B-9.22%
2009C$71.66 B-0.76%
2008C$72.21 B16.02%
2007C$62.23 B-34.84%
2006C$95.51 B5.11%
2005C$90.87 B26.47%
2004C$71.85 B-32.37%
2003C$106.25 B11.55%
2002C$95.25 B-26.48%
2001C$129.56 B-4.91%
2000C$136.25 B27.41%
1999C$106.94 B63.18%
1998C$65.53 B34.25%
1997C$48.81 B34.38%
1996C$36.32 B

End of Day market cap according to different sources

On Oct 6th, 2026 the market cap of AstraZeneca was reported to be:

C$350.60 Billion
by Nasdaq info icon info icon
C$350.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
C$887.98 B 150.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$388.26 B 9.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$227.53 B-35.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$245.17 B-30.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$1.510 T 326.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$137.33 B-61.21%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$46.79 B-86.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$502.25 B 41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$173.86 B-50.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$134.30 B-62.06%๐Ÿ‡ฌ๐Ÿ‡ง UK